103.72
前日終値:
$102.88
開ける:
$102.62
24時間の取引高:
231.09K
Relative Volume:
0.82
時価総額:
$2.37B
収益:
$256.28M
当期純損益:
$62.40M
株価収益率:
38.22
EPS:
2.7139
ネットキャッシュフロー:
$79.12M
1週間 パフォーマンス:
+8.04%
1か月 パフォーマンス:
+9.78%
6か月 パフォーマンス:
+24.20%
1年 パフォーマンス:
+22.91%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Compare LMAT vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LMAT
Lemaitre Vascular Inc
|
103.72 | 2.19B | 256.28M | 62.40M | 79.12M | 2.7139 |
|
ISRG
Intuitive Surgical Inc
|
432.83 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
155.54 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
42.75 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
68.33 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
218.40 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 開始されました | Wells Fargo | Equal Weight |
| 2024-10-15 | 開始されました | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 再開されました | Lake Street | Buy |
| 2024-05-31 | 再開されました | ROTH MKM | Buy |
| 2024-04-26 | アップグレード | Stifel | Hold → Buy |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-06 | 開始されました | Oppenheimer | Outperform |
| 2023-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 開始されました | Jefferies | Buy |
| 2021-02-12 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | アップグレード | Sidoti | Neutral → Buy |
| 2019-10-24 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | アップグレード | Lake Street | Hold → Buy |
| 2019-10-14 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 繰り返されました | Barrington Research | Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 再開されました | ROTH Capital | Buy |
| 2018-04-26 | ダウングレード | Stifel | Buy → Hold |
| 2018-04-26 | アップグレード | The Benchmark Company | Hold → Buy |
| 2017-10-27 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-07-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 開始されました | First Analysis Sec | Overweight |
| 2017-02-22 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-07-28 | 繰り返されました | Barrington Research | Outperform |
| 2016-02-25 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Lemaitre Vascular Inc (LMAT) 最新ニュース
LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position - MarketBeat
LeMaitre Vascular, Inc. Financial Disclosures & Filings - TradingView
LMATLemaitre Vascular Inc Latest SEC Filings - Finviz
LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC - MarketBeat
Trading the Move, Not the Narrative: (LMAT) Edition - Stock Traders Daily
Price to sales forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Enterprise value to EBIT forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT) - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU) - TradingView
LeMaitre Vascular Inc (LMAT) Institutional Confidence - TradingKey
LMAT Forecast — Price Target — Prediction for 2027 - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU) - TradingView
LHU Forecast — Price Target — Prediction for 2027 - TradingView
Rockefeller Capital Management L.P. Sells 100,923 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc (LMAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Riverbridge Partners LLC Buys Shares of 105,599 LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc. (NASDAQ:LMAT) Passes the Quality Test with Caviar Cruise Screen - ChartMill
LeMaitre Vascular Inc (LMAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
LeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at Wall Street Zen - MarketBeat
LeMaitre Vascular Inc (LMAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LeMaitre Vascular Inc (LMAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LeMaitre Vascular Inc (LMAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LeMaitre Vascular Inc (LMAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LeMaitre Vascular Inc (LMAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
(LMAT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Shareholders Back Directors, Pay and Auditor - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LeMaitre Vascular declares $0.25 dividend - MSN
LeMaitre Vascular (NASDAQ:LMAT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
LMAT Q1 2026 Earnings: EPS Slightly Beats Estimates, Shares RiseEarnings Deceleration Risk - newsline.com
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Slightly Beats Estimates Amid Modest Stock Uptick - newsline.com
Jefferies recaps meetings with Healthcare Services companies - Investing.com
LMAT Q1 2026 Earnings: EPS Beats Estimates by 0.86%, Shares Inch HigherAnnual Report - newsline.com
LeMaitre Vascular (NASDAQ: LMAT) director gets dividend equivalent awards - Stock Titan
LeMaitre Vascular (LMAT) director receives new dividend equivalent rights grants - Stock Titan
LeMaitre (NASDAQ: LMAT) director gets dividend equivalent right awards - Stock Titan
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent rights awards - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CFO receives new dividend rights awards - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent right grants - Stock Titan
LeMaitre Vascular (LMAT) awards dividend equivalent rights to executive - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CEO gifts 11,974 shares, receives dividend rights - Stock Titan
Price-Driven Insight from (LMAT) for Rule-Based Strategy - Stock Traders Daily
LeMaitre Vascular (LMAT) holders approve directors, say-on-pay and 2026 auditor - Stock Titan
LeMaitre Vascular (LMAT) Gains Ground as Stock Approaches Key ResistanceUndervalued Stocks - newsline.com
LMAT Maintained by Barrington Research -- Price Target Steady at $120 - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Receives Outperform Rating from Barrington Research - MarketBeat
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120 - Moomoo
Q3 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
Lemaitre Vascular Inc (LMAT) 財務データ
収益
当期純利益
現金流量
EPS
Lemaitre Vascular Inc (LMAT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LeMaitre George W | Chairman and CEO |
May 07 '26 |
Sale |
107.64 |
18,600 |
2,002,013 |
1,457,900 |
| Kamke Trent G | Senior V. P., Operations |
May 08 '26 |
Sale |
107.00 |
2,928 |
313,287 |
3,749 |
| Ross Bridget A | Director |
May 07 '26 |
Option Exercise |
48.15 |
5,044 |
242,882 |
8,986 |
| Ross Bridget A | Director |
May 07 '26 |
Sale |
111.10 |
5,044 |
560,366 |
3,942 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Option Exercise |
65.92 |
2,858 |
188,412 |
8,657 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Sale |
110.00 |
3,943 |
433,730 |
4,714 |
大文字化:
|
ボリューム (24 時間):